Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2024-05-14 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Notification Letter and Request Form to Non-registered Shareholders - Notification of publication of Circular and Notice of the 2023 Annual General Meeting and 2024 First H Share Class Meeting
Report Publication Announcement Classification · 100% confidence The document is a notification letter dated May 14, 2024, from Pharmaron Beijing Co., Ltd. It informs non-registered shareholders about the publication of several corporate communications on the company's and HKEX's websites. These communications include (1) Circular of the 2023 Annual General Meeting & 2024 First H Share Class Meeting, (2) Notice of 2023 Annual General Meeting, and (3) Notice of 2024 First H Share Class Meeting. The letter also provides instructions on how shareholders can request printed copies of these communications. The document does not contain the actual reports or meeting materials but rather announces their availability and provides a request form for printed copies. It is a typical example of a Report Publication Announcement (RPA), as it announces the publication of reports and notices but does not include substantive financial data or meeting content itself.
2024-05-14 English
Notification Letter and Request Form to H Shareholders - Notification of publication of Circular, Notice and Proxy Form for the 2023 Annual General Meeting and 2024 First H Share Class Meeting
Report Publication Announcement Classification · 95% confidence The document is a notification letter from Pharmaron Beijing Co., Ltd. dated May 14, 2024, informing shareholders about the publication of several corporate communications related to the 2023 Annual General Meeting and the 2024 First H Share Class Meeting. It mentions the availability of the circular, notices of meetings, and proxy forms on the company's website and the HKEX website. The document also includes a request form for shareholders to receive printed versions of these communications if they have difficulty accessing them online. The content is primarily an announcement about the availability and distribution of meeting-related documents rather than the documents themselves. The document is relatively short (7,167 characters) and serves as a notification rather than a full report or meeting materials. Therefore, it fits the definition of a Report Publication Announcement (RPA), which is an announcement regarding the timing, release, or publication of company reports or communications, often stating that the report is attached or available on the website.
2024-05-14 English
Form of Proxy for the First H Share Class Meeting of 2024
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for the First H Share Class Meeting of 2024 of Pharmaron Beijing Co., Ltd. It is intended for shareholders to appoint a proxy to vote on their behalf at a specific shareholder meeting. The content includes instructions on how to fill out the proxy form, details about the meeting date and location, and voting options on special resolutions related to capital increases and amendments to the Articles of Association. This document is not a report or financial statement but a proxy solicitation material for a shareholder meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is 5384 characters, which is consistent with a detailed proxy form rather than a brief announcement or a full report.
2024-05-14 English
Form of Proxy for the Annual General Meeting of 2023 (Applicable to H Shareholders)
AGM Information Classification · 100% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of Pharmaron Beijing Co., Ltd. for the year 2023. It includes instructions for shareholders to appoint proxies to vote on various resolutions at the AGM, including approval of the annual report, financial statements, profit distribution, remuneration, and amendments to company policies. The document is not the annual report itself but a proxy form related to the AGM. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms.
2024-05-14 English
NOTICE OF THE FIRST H SHARE CLASS MEETING OF 2024
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for the first H Share Class Meeting of 2024 for Pharmaron Beijing Co., Ltd. It includes details about the meeting date, location, agenda items (such as increases in registered capital and amendments to articles of association), proxy voting instructions, and closure of the register of members. It does not contain financial statements or detailed financial analysis but serves as an announcement to shareholders about the upcoming meeting and the resolutions to be considered. The document is over 6,000 characters, indicating it is not a brief announcement but a formal notice. This type of document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a voting result announcement or management change notice. Therefore, the correct classification is PSI with high confidence.
2024-05-14 English
NOTICE OF THE ANNUAL GENERAL MEETING OF 2023
AGM Information Classification · 100% confidence The document is a notice for the Annual General Meeting (AGM) of Pharmaron Beijing Co., Ltd. for the year 2023. It includes details about the meeting date, location, agenda items such as approval of financial statements, profit distribution, remuneration, amendments to policies, and capital changes. It also provides procedural information about shareholder registration, proxy appointments, and voting. The document is clearly a notice announcing the AGM and the matters to be discussed and voted on, rather than the actual AGM materials or reports themselves. The length is under 10,000 characters and it serves as an invitation and agenda notice. Therefore, it fits the category of AGM Information (AGM-R).
2024-05-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.